RxSight Inc. (RXST): Wells Fargo sees 76% upside potential and competitive advantage!
Reading Time: 2 minutes
RxSight Inc. (RXST) is a medtech company that specializes in the development and marketing of the world’s first and only light adjustable intraocular lens (Light Adjustable Lens, LAL) that can be individually adjusted after cataract surgery. This innovative product enables surgeons to precisely optimize their patients' vision post-operation, representing a significant advancement in the treatment of cataracts. RxSight Inc. reports strong growth in Q1 2025 On May 7, the company presented its report for Q1. According to the report, revenue increased...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
